A kinome screen reveals that Nemo-like kinase is a key suppressor of hepatic gluconeogenesis
Authors:
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Cell Metabolism
- Vol. 33 (6) , 1171-1186.e9
Abstract
No abstract availableKeywords
Funding Information
- National Science Fund for Distinguished Young Scholars (81425005)
- National Key Research and Development Program of China (2016YFF0101504)
- Wuhan University
- National Natural Science Foundation of China (81630011)
- National Natural Science Foundation of China (31700759)
- National Natural Science Foundation of China (81800252)
- National Natural Science Foundation of China (91729303)
- National Natural Science Foundation of China (91639304)
This publication has 66 references indexed in Scilit:
- Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes MellitusArchives of internal medicine (1960), 2012
- NLK positively regulates Wnt/β‐catenin signalling by phosphorylating LEF1 in neural progenitor cellsThe EMBO Journal, 2012
- Regulation of FOXO1 by TAK1-Nemo-like Kinase PathwayJournal of Biological Chemistry, 2010
- Nemo-like kinase suppresses Notch signalling by interfering with formation of the Notch active transcriptional complexNature Cell Biology, 2010
- Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic GluconeogenesisCell Metabolism, 2010
- A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchangeNature, 2008
- Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2Proceedings of the National Academy of Sciences, 2008
- SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein KinaseJournal of Biological Chemistry, 2008
- Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice†Hepatology, 2007
- The CREB coactivator TORC2 is a key regulator of fasting glucose metabolismNature, 2005